Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Vaccines

Free Subscription Articles published in AIDS Retrieve available abstracts of 19 articles: HTML format

Single Articles

June 2022
1. POURCHER V, Belin L, Soulie C, Rosenzwajg M, et al
   High seroconversion rate and SARS-CoV-2 Delta neutralization in PLWHIV vaccinated with BNT162b2.
   AIDS. 2022 Jun 23. pii: 00002030-990000000-00043.
   PubMed     Abstract available
   
   
   April 2022
2. WONG NS, Wong BCK, Chan JMC, Wong KH, et al
   Surrogate neutralisation responses following SARS-CoV-2 vaccination in people living with HIV - comparison between inactivated and mRNA vaccine.
   AIDS. 2022 Apr 23. pii: 00002030-990000000-00010.
   PubMed     Abstract available
   
   
   March 2022
3. LEFEBVRE M, Secher S, Bouchez S, Vandamme YM, et al
   Measles seroprevalence in human immunodeficiency virus-infected adults born in the era of measles vaccination.
   AIDS. 2022 Mar 8. pii: 00002030-990000000-00002.
   PubMed     Abstract available
   
   
   
4. XU X, Vesterbacka J, Aleman S, Nowak P, et al
   High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV - but HIV viremia matters?
   AIDS. 2022;36:479-481.
   PubMed     Abstract available
   
   
   February 2022
5. DURIER C, Mercier-Delarue S, Verdiere NC, Meiffredy V, et al
   A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults.
   AIDS. 2022;36:319-321.
   PubMed    
   
   
   
6. SHAVER ZM, Anderson M, Bhebhe L, Baruti K, et al
   Decreased HBV vaccine response among HIV positive infants compared to HIV negative infants in Botswana.
   AIDS. 2022 Feb 1. pii: 00002030-900000000-96228.
   PubMed     Abstract available
   
   
   January 2022
7. HASSOLD N, Brichler S, Ouedraogo E, Leclerc D, et al
   Impaired antibody response to COVID-19 vaccination in advanced HIV infection.
   AIDS. 2022 Jan 10. pii: 00002030-900000000-96241.
   PubMed     Abstract available
   
   
   
8. ALEDO MG, Canizares A, Vazquez-Rodriguez P, Castro A, et al
   Safety and immunogenicity of SARS-CoV-2 mRNA-1273 and BNT162b2 vaccines in people living with HIV.
   AIDS. 2022 Jan 6. pii: 00002030-900000000-96246.
   PubMed     Abstract available
   
   
   December 2021
9. SPINELLI MA, Brown LB, Glidden DV, Hunter K, et al
   SARS-CoV-2 incidence, testing rates, and severe COVID-19 outcomes among people with and without HIV.
   AIDS. 2021;35:2545-2547.
   PubMed     Abstract available
   
   
   November 2021
10. MOHAPI L, Pinedo Y, Osiyemi O, Supparatpinyo K, et al
    Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV: a randomized phase 3 study.
    AIDS. 2021 Nov 8. pii: 00002030-900000000-96271.
    PubMed     Abstract available
    
    
    October 2021
11. TOMIO A, Lupo J, Blanc M, Epaulard O, et al
    Dynamics of anti-HBs antibody decay in vaccinated people with HIV/AIDS.
    AIDS. 2021;35:2059-2061.
    PubMed    
    
    
    August 2021
12. MARASINI B, Vyas HK, Lakhashe SK, Hariraju D, et al
    Mucosal AIDS virus transmission is enhanced by antiviral IgG isolated early in infection.
    AIDS. 2021 Aug 16. pii: 00002030-900000000-96332.
    PubMed     Abstract available
    
    
    July 2021
13. RUDDY JA, Boyarsky BJ, Bailey JR, Karaba AH, et al
    Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV.
    AIDS. 2021 Jul 8. pii: 00002030-900000000-96349.
    PubMed     Abstract available
    
    
    June 2021
14. LIU G, Mugo NR, Brown ER, Mgodi NM, et al
    Prevalent HPV infection increases the risk of HIV acquisition in African women: advancing the argument for HPV immunization.
    AIDS. 2021 Jun 24. pii: 00002030-900000000-96360.
    PubMed     Abstract available
    
    
    
15. NDUATI EW, Gorman MJ, Sein Y, Hermanus T, et al
    Coordinated Fc-effector and neutralization functions in HIV-infected children define a window of opportunity for HIV vaccination.
    AIDS. 2021 Jun 10. pii: 00002030-900000000-96374.
    PubMed     Abstract available
    
    
    May 2021
16. RUDDY JA, Boyarsky BJ, Werbel WA, Bailey JR, et al
    Safety and antibody response to the first dose of SARS-CoV-2 messenger RNA vaccine in persons with HIV.
    AIDS. 2021 May 14. pii: 00002030-900000000-96405.
    PubMed     Abstract available
    
    
    
17. GOSENS KCM, van der Zee RP, van Heukelom MLS, Jongen VW, et al
    HPV vaccination to prevent recurrence of Anal Intraepithelial Neoplasia in HIV+ MSM: a randomised, placebo-controlled multicentre trial.
    AIDS. 2021 May 5. pii: 00002030-900000000-96413.
    PubMed     Abstract available
    
    
    April 2021
18. PREININGER L, Kahal DA, Szabo S
    Hepatitis B vaccination response and safety in people living with HIV/AIDS receiving HepB-CpG series.
    AIDS. 2021;35:845-846.
    PubMed    
    
    
    August 2019
19. FRENCH M
    Antibody-mediated control of HIV-1 infection through an alternative pathway.
    AIDS. 2019 Aug 1. doi: 10.1097/QAD.0000000000002313.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: